FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to medicine and chemical-pharmaceutical industry, particularly to a medicinal agent for treating cerebral diseases and to a method of treating and preventing such diseases. As an active ingredient, drug contains 6-methyl-2-ethylpyridine-3-ol(2S)-2-acetaminopentanedioic acid salt in a pharmacologically effective dose for treating and preventing cerebral diseases, in particular, acute cerebral circulation disorders and encephalopathies of various genesis, as well as a method of treating said diseases using said medicinal agent.
EFFECT: implementation of inventions widens the range of products for treating cerebral diseases, as well as intensified pharmacological activity with simultaneous reduction of drug load on the patient.
8 cl, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF CEREBROVASCULAR BRAIN DISORDERS (OPTIONS) | 2017 |
|
RU2659674C1 |
PHARMACEUTICAL NEUROPROTECTIVE, ANTIOXIDANT, ANTIHYPOXIC, ANTIAPOPTOTIC AND MEMBRANE PROTECTIVE COMPOSITION AND METHOD OF TREATMENT | 2008 |
|
RU2385722C1 |
METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION HAVING NEUROPROTECTIVE ACTIVITY IN CHRONIC CEREBRAL ISCHEMIA | 2023 |
|
RU2816359C1 |
DRUG WITH ANTIHYPOXIC, ANTIAMNESTIC AND NEUROPROTECTIVE ACTIVITY | 2020 |
|
RU2750418C1 |
MEANS FOR TREATING ISCHEMIA OF VASCULAR BRAINS | 2016 |
|
RU2625740C1 |
USE OF PHARMACEUTICAL COMPOSITION CONTAINING CHOLINE ALFOSCERATE AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE AS NEUROPROTECTIVE AGENT IN CEREBRAL ISCHEMIA | 2023 |
|
RU2819828C1 |
AGENT FOR TREATMENT OF ACUTE AND CHRONIC DISTURBANCES OF CEREBRAL CIRCULATION, INCLUDING STROKE ON BASIS OF HYDROGENATED PYRIDO (4,3-b)INDOLES (VERSIONS), PHARMACOLOGICAL AGENT ON ITS BASIS AND METHOD OF ITS APPLICATION | 2006 |
|
RU2340342C2 |
APPLICATION OF BETA-HYDROXYBUTYRATE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR PREPARATION OF MEDICATION WHICH POSSESSES CYTOPROTECTIVE ACTIVITY, INCLUDING NEUROPROTECTIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC, ANTI-HYPOXIC, ANTI-STRESS, ACTOPROTECTIVE AND ADAPTOGENIC ACTIVITY, MEDICATION AND METHOD OF PREVENTION, RELIEF AND TREATMENT BY MEANS OF SAID MEDICATION | 2009 |
|
RU2426535C2 |
NEUROTROPIC PREPARATION, POSSESSING ANTI-HYPOXIC, NEUROPROTECTIVE, ANTI-AMNESTIC AND VESTIBULAR-PROTECTIVE ACTIVITY | 2014 |
|
RU2547728C1 |
MEDICATION FOR TREATING CEREBRAL CIRCULATION DISORDERS AND BRAIN TRAUMAS | 2012 |
|
RU2554502C9 |
Authors
Dates
2019-06-20—Published
2015-03-12—Filed